Thermo Fisher jumps on the US investment bandwagon with $2B in additional spending
Title
Thermo Fisher Commits $2 Billion to Expand U.S. Manufacturing and Innovation Amid Industry Shift
Keywords
- Thermo Fisher Scientific
- U.S. manufacturing investment
- Life sciences sector
- Research and development (R&D)
- Biopharmaceuticals
- Economic competitiveness
- Healthcare supply chain
- Trump tariffs
- Domestic production
- Pharmaceutical manufacturing
Key Facts
- Thermo Fisher Scientific will invest an additional $2 billion in the United States over the next four years to strengthen American innovation, manufacturing, and economic competitiveness across the life sciences sector123.
- Of the total investment, $1.5 billion is allocated for capital expenditures aimed at enhancing and expanding U.S. manufacturing operations, while $500 million is dedicated to expanding research and development efforts12345.
- This move follows a broader industry trend as companies like Roche, Johnson & Johnson, Eli Lilly, and Novartis have also announced significant U.S. investments in response to geopolitical uncertainties and potential new tariffs on imports23.
- Thermo Fisher’s expanded U.S. operations are expected to reinforce the resilience of the domestic healthcare supply chain, ensuring the ongoing development and production of life-saving medicines and therapies within the country123.
- The company currently operates 64 manufacturing sites across 37 U.S. states, supporting biopharma production with analytical instruments, specialty diagnostics, and contract manufacturing services123.
- This investment builds on Thermo Fisher’s recent acquisition activity and is seen as both a proactive response to potential trade barriers and a sign of long-term confidence in America’s role as a global leader in science and innovation123.
- Thermo Fisher employs more than 50,000 people in the U.S. and reported global revenues of $43 billion last year2.
- The company has not yet disclosed specific details on whether the new investment will be used to expand existing sites, build new facilities, or both3.
Sources:
1. https://ir.thermofisher.com/investors/news-events/news/news-details/2025/Thermo-Fisher-Scientific-Invests-to-Enhance-U-S--Innovation-and-Support-Customers-Manufacturing/default.aspx
2. https://www.fiercepharma.com/manufacturing/thermo-fisher-joins-us-investment-bandwagon-2b-plan
3. https://www.pharmaceutical-technology.com/news/thermo-fisher-counters-tariffs-with-2bn-investment-into-us-manufacturing/
4. https://pharmasource.global/content/news/cdmo-news/thermo-fisher-to-invest-2-billion-in-u-s-life-sciences-manufacturing/
5. https://www.mddionline.com/business/thermo-fisher-lowers-2025-guidance-as-trump-tariffs-research-cuts-take-toll